Prevalence of bacterial vaginosis, sexually transmitted infections and their association with HPV infections in asymptomatic women attending antenatal care in Ethiopia.

Johanna M A Klein, Isabel Runge, Ann-Katrin Pannen, Tariku Wakuma, Semaw Ferede Abera, Adamu Adissie, Susanne Unverzagt, Markus Schmitt, Tim Waterboer, Daniela Höfler, Christoph Thomssen, Eva Johanna Kantelhardt
Author Information
  1. Johanna M A Klein: Department of Gynaecology, Martin Luther University Halle-Wittenberg, Halle (Saale) 06097, Germany.
  2. Isabel Runge: Department of Gynaecology, Martin Luther University Halle-Wittenberg, Halle (Saale) 06097, Germany.
  3. Ann-Katrin Pannen: Department of Gynaecology, Martin Luther University Halle-Wittenberg, Halle (Saale) 06097, Germany.
  4. Tariku Wakuma: Global Health Working Group, Martin Luther University Halle-Wittenberg, Halle (Saale) 06097, Germany.
  5. Semaw Ferede Abera: Department of Radiation Oncology, Faculty of Medicine, Martin Luther University Halle-Wittenberg, Halle (Saale) 06097, Germany.
  6. Adamu Adissie: Global Health Working Group, Martin Luther University Halle-Wittenberg, Halle (Saale) 06097, Germany.
  7. Susanne Unverzagt: Institute of General Practice and Family Medicine, Center of Health Sciences, Martin Luther University Halle-Wittenberg, Halle (Saale) 06097, Germany.
  8. Markus Schmitt: Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.
  9. Tim Waterboer: Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.
  10. Daniela Höfler: Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.
  11. Christoph Thomssen: Department of Gynaecology, Martin Luther University Halle-Wittenberg, Halle (Saale) 06097, Germany.
  12. Eva Johanna Kantelhardt: Department of Gynaecology, Martin Luther University Halle-Wittenberg, Halle (Saale) 06097, Germany.

Abstract

Sexually transmitted infections (STIs) and human papillomavirus (HPV) infections are common among women of reproductive age and can lead to infertility, adverse pregnancy outcomes, neonatal infections and cervical cancer. In countries with limited medical coverage, untreated infections contribute to high morbidity. This study aimed to expand the current knowledge on the prevalence of bacterial vaginosis (BV) and STIs in pregnant Ethiopian women and assess the association of these conditions with HPV infections. Socio-demographic data and vaginal lavage samples were collected from 779 asymptomatic women aged 18 to 45 years (median age, 25.9 years) attending antenatal care in seven centres across Ethiopia. Multiplex polymerase chain reaction was used to test for BV, , , , herpes simplex virus types 1 and 2 (HSV-1/2), , , and HPV. Overall, 26.8% (95% confidence interval (CI): 23.7-29.9) of women tested positive for BV or one of the following STIs: , , , , HSV-1/2 or . Additionally, 22.1% tested positive for at least one high-risk HPV type. and HSV-2 were significantly more common among women who were positive for HPV and high-risk HPV. This study reveals a high prevalence of asymptomatic pregnant women who are positive for BV, STIs or HPV, putting them at risk of adverse pregnancy outcomes, secondary infertility or cervical cancer in a country with limited medical coverage. Screening and treating these women could be crucial in reducing morbidity.

Keywords

References

  1. Sex Transm Infect. 2020 Aug;96(5):322-329 [PMID: 31836678]
  2. Eur J Dermatol. 2014 Sep-Oct;24(5):611-6 [PMID: 25322708]
  3. J Clin Pathol. 2002 Apr;55(4):244-65 [PMID: 11919208]
  4. J Natl Cancer Inst. 2002 Nov 6;94(21):1604-13 [PMID: 12419786]
  5. Sex Transm Infect. 2022 Nov;98(7):484-491 [PMID: 34887350]
  6. Front Public Health. 2020 Dec 10;8:567885 [PMID: 33363078]
  7. PLoS One. 2022 Feb 25;17(2):e0262692 [PMID: 35213556]
  8. Clin Infect Dis. 2019 Oct 15;69(9):1517-1525 [PMID: 31504315]
  9. Afr J AIDS Res. 2009 Jun;8(2):135-46 [PMID: 25875565]
  10. Int J Public Health. 2019 Jul;64(6):943-955 [PMID: 31175391]
  11. J Infect. 2014 Aug;69(2):123-33 [PMID: 24814157]
  12. Infect Drug Resist. 2022 Jun 16;15:3077-3086 [PMID: 35754781]
  13. Clin Microbiol Infect. 2014 Oct;20(10):1074-9 [PMID: 24849820]
  14. Sex Transm Infect. 2005 Aug;81(4):294-302 [PMID: 16061534]
  15. Sex Transm Infect. 2015 Nov;91(7):473-8 [PMID: 25834122]
  16. J Clin Microbiol. 2008 Mar;46(3):1050-9 [PMID: 18199790]
  17. Am J Epidemiol. 2005 Oct 1;162(7):668-75 [PMID: 16120706]
  18. BMC Infect Dis. 2011 Jan 11;11:10 [PMID: 21223574]
  19. Ecancermedicalscience. 2024 Aug 14;18:1739 [PMID: 39421164]
  20. J Sex Transm Dis. 2015;2015:310409 [PMID: 26605102]
  21. Am J Obstet Gynecol. 2008 Jan;198(1):43.e1-5 [PMID: 18166302]
  22. PLoS One. 2021 Mar 24;16(3):e0248958 [PMID: 33760867]
  23. N Engl J Med. 1998 Feb 12;338(7):423-8 [PMID: 9459645]
  24. J Med Virol. 2012 Dec;84(12):1920-7 [PMID: 23080497]
  25. Sci Rep. 2024 Apr 29;14(1):9813 [PMID: 38684716]
  26. BMC Res Notes. 2014 Nov 20;7:822 [PMID: 25409756]
  27. Emerg Infect Dis. 2019 Aug;25(8):1469-1476 [PMID: 31310223]
  28. Sex Transm Infect. 2019 Feb;95(1):60-66 [PMID: 30228109]
  29. Int J Cancer. 2013 May 15;132(10):2395-403 [PMID: 23034864]
  30. Acta Obstet Gynecol Scand. 2015 Sep;94(9):989-96 [PMID: 26084843]
  31. Pediatrics. 2016 Apr;137(4): [PMID: 26933212]
  32. J Clin Virol. 2018 Jul;104:48-55 [PMID: 29729547]
  33. Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1731-8 [PMID: 18628425]
  34. Pediatr Infect Dis J. 2016 Aug;35(8):894-900 [PMID: 27164464]
  35. J Infect Dis. 2010 Dec 15;202(12):1789-99 [PMID: 21067372]
  36. N Engl J Med. 2001 Aug 16;345(7):487-93 [PMID: 11519502]
  37. Lancet. 2003 Mar 22;361(9362):983-8 [PMID: 12660054]
  38. Clin Infect Dis. 2015 Dec 15;61 Suppl 8:S837-48 [PMID: 26602621]
  39. Int J STD AIDS. 2018 Mar;29(3):251-258 [PMID: 28776463]
  40. Matern Child Health J. 2018 Jun;22(6):812-821 [PMID: 29417367]

Word Cloud

Created with Highcharts 10.0.0HPVwomeninfectionsBVpositivetransmittedSTIspregnancybacterialvaginosisasymptomaticEthiopiahumanpapillomaviruscommonamongageinfertilityadverseoutcomescervicalcancerlimitedmedicalcoveragehighmorbiditystudyprevalencepregnantassociationvaginallavageyears9attendingantenatalcareHSV-1/2testedonehigh-risksexuallySexuallyreproductivecanleadneonatalcountriesuntreatedcontributeaimedexpandcurrentknowledgeEthiopianassessconditionsSocio-demographicdatasamplescollected779aged1845median25sevencentresacrossMultiplexpolymerasechainreactionusedtestherpessimplexvirustypes12Overall268%95%confidenceintervalCI:237-29followingSTIs:Additionally221%leasttypeHSV-2significantlyrevealsputtingrisksecondarycountryScreeningtreatingcrucialreducingPrevalencediseases

Similar Articles

Cited By